Wangting Xu
Impact in
-
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
-
- Ferroptosis and cancer prognosis
Papers in
-
- Epigenetics and DNA Methylation 2
- Protein Tyrosine Phosphatases 2
- Peroxisome Proliferator-Activated Receptors 1
- Angiogenesis and VEGF in Cancer 1
-
- Ferroptosis and cancer prognosis 3
- Co-authors
- Yuehai Ke (4 shared papers)Xue Zhang (4 shared papers)Hongqiang Cheng (4 shared papers)Yiqing Li (3 shared papers)Pengwei Zhao (1 shared paper)Yuxian Guo (1 shared paper)Di Wang (1 shared paper)Yaru Liu (2 shared papers)
- Journals
- Cancer Letters (1 paper)Research (1 paper)Advanced Science (1 paper)Biomarker Research (1 paper)Clinical Immunology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Wangting Xu
10 papers receiving 341 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 54
- Pulmonary and Respiratory Medicine 113
- Immunology 70
- Biochemistry 18
- Molecular Biology 154
Countries citing papers authored by Wangting Xu
This map shows the geographic impact of Wangting Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wangting Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wangting Xu more than expected).
Fields of papers citing papers by Wangting Xu
This network shows the impact of papers produced by Wangting Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wangting Xu. The network helps show where Wangting Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wangting Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 145 | |
| 2 | 2021 | 56 | |
| 3 | 2022 | 48 | |
| 4 | 2023 | 46 | |
| 5 | 2025 | 19 | |
| 6 | 2024 | 13 | |
| 7 | 2025 | 7 | |
| 8 | 2021 | 5 | |
| 9 | 2025 | 2 | |
| 10 | 2024 | 2 | |
| 11 | 2025 | 0 |
About Wangting Xu
Wangting Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Immunology, Cancer Research and Biological Psychiatry, having authored 11 papers that have together received 343 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (3 papers), Epigenetics and DNA Methylation (2 papers), Protein Tyrosine Phosphatases (2 papers), Cancer, Lipids, and Metabolism (2 papers), Immune cells in cancer (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper), Angiogenesis and VEGF in Cancer (1 paper) and Galectins and Cancer Biology (1 paper). The work is most often cited by research in Cancer Research (54 citations), Pulmonary and Respiratory Medicine (113 citations), Immunology (70 citations), Biochemistry (18 citations) and Molecular Biology (154 citations). Wangting Xu has collaborated with scholars based in China and United States. Frequent co-authors include Yuehai Ke, Xue Zhang, Hongqiang Cheng, Yiqing Li, Pengwei Zhao, Yuxian Guo, Di Wang, Yaru Liu, Bufu Tang and Rongfang Qiu. Their work appears in journals such as Cancer Letters, Research, Advanced Science, Biomarker Research and Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.